Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003162 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 949
- Enrollment target
NCT00003162: Completed Phase 3 study, sponsored by Radiation Therapy Oncology Group.
NCT00003162 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 949 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003162, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 949 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.
Interventions
- RADIATION radiation therapy
- PROCEDURE pain therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 949 participants |
| Start Date | 1998-02 |
| Phase | Phase 3 |
What the finished NCT00003162 record still lists
NCT00003162 is an interventional study that assigns participants to a tested intervention. The registered 949 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00003162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003162 about?
NCT00003162 is a clinical study titled "Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases fr...
What is the current status of trial NCT00003162?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 949 participants. The study started on 1998-02.
What interventions are being tested in trial NCT00003162?
The interventions under investigation include: radiation therapy (RADIATION), pain therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00003162?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003162's enrollment target sits among peer trials
949 334th of 2000 higher than 1,667 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- NCT06087224 · 947 participants · NA
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia